Prognostic value of serial measurements of left ventricular function and exercise performance in chronic heart failure;Valor pronóstico de las medidas seriadas de la función ventricular izquierda y del rendimiento en el ejercicio en la insuficiencia cardiaca crónica

Revista Espanola de Cardiologia

Volumn 59, Issue 9, 2006, Pages 905-910

  Moreo, Antonella ^a,b   de Chiara, Benedetta ^a   Cataldo, Gabriella ^a   Piccalò, Giacomo ^a   Lobiati, Elisabetta ^a   Parolini, Marina ^a   Frigerio, Maria ^a   Ciliberto, Guglielma Rita ^b   Mauri, Francesco ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b NONE

Author keywords

Echocardiography; Heart failure; Prognosis

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTIVARIATE ANALYSIS; PROGNOSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

EID: 33750977286     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13092798     Document Type: Article

References (20)

1. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol. 1987;59:634-8.
2. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, et al. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol. 1989;14:564-70.
3. Parameshwar J, Keegan J, Sparrow J, Sutton GC, Poole-Wilson PA. Predictors of prognosis in severe chronic heart failure. Am Heart J. 1992;123:421-6.
4. Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 1993;87 Suppl VI:5-16.
5. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778-86.
6. Van den Broek SAJ, van Veldhuisen DJ, de Graff PA, Landsman MLJ, Lie KI. Comparison between New York Heart Association Classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;70:359-63.
7. Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 1985;55:1037-42.
8. Haywood GA, Rickenbacher PR, Trindade PT, Gullestad L, Jiang JP, Schroeder JS, et al. Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria. Heart. 1996;75:455-62.
9. Stevenson LW, Steimle AE, Fonarow G, Kermani M, Kermani D, Hamilton MA, et al. Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol. 1995;25:163-70.
10. Gullestad L, Myers J, Ross H, Rickenbacher P, Slauson S, Bellin D, et al. Serial exercise testing and prognosis in selected patients considered for cardiac transplantation. Am Heart J. 1998;135:221-9.
11. Cintron G, Johnson G, Francis G, Cobb F, Cohn JN. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation. 1993;87 Suppl VI:17-23.
12. Florea VG, Henein MY, Anker SD, Francis DP, Chambers JS, Ponikowski P, et al. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. Eur Heart J. 2000;21:146-53.
13. Wasserman K, Hansen JE, Sue DY, Whipp BJ, Casaburi R. Principles of Exercise Testing and Interpretation. 2nd ed. Philadelphia: Lea & Febiger; 1994.
14. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by 2-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358-67.
15. Levine TB, Levine AB, Goldberg D, Narins B, Goldstein S, Lesch M. Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohumoral profile. J Heart Lung Transplant. 1996;15:297-303.
16. Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol. 1995;25:1225-31.
17. Carson PE. Beta-blocker treatment in heart failure. Prog Cardiovasc Dis. 1999;41:301-22.
18. Bohm M, Maack C. Treatment of heart failure with beta-blockers: mechanisms and results. Basic Res Cardiol. 2000;95 Suppl I:15-24.
19. Zugck C, Haunstetter A, Kruger C, Kell R, Schellberg D, Kubler W, et al. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol. 2002;39:1615-22.
20. Alameda M, Moya JL, García Lledó JA, Alonso Recarte M, Guzman G, Vaticón C, et al. Valoración pronóstica de los pacientes con disfunción sistólica: estudio funcional y ecocardiográfico. Rev Esp Cardiol. 2002;55:372-82.